Immunotherapy drug opens a new era of precision medicine for cancer
(LA Times Television)

With little fanfare, the Food and Drug Administration did something this week that it`s never done before: The agency approved a single prescription drug, pembrolizumab (marketed by Merck as Keytruda) for treatment of solid tumors in any organ so long as the malignancy bears a specific genetic...